Lärkberget AB (publ) (STO:COMBI)

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2018	FY 2017
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2018	Dec 31, 2017
Novel Gene Therapies	5.54M	Log In	Log In	Log In	Log In
Novel Gene Therapies Growth	-79.23%	Log In	Log In	Log In	Log In

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2018	FY 2017
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2018	Dec 31, 2017
Sweden	5.54M	Log In	Log In	Log In	Log In
Sweden Growth	-79.23%	Log In	Log In	Log In	Log In